Drug
Rocuronium
[ DR10000000728 ]
- Summary
- Rocuronium (rapid onset-curonium) is a desacetoxy analogue of vecuronium with a more rapid onset of action. It is an aminosteroid non-depolarizing neuromuscular blocker or muscle relaxant used in modern anaesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Introduced in 1994, rocuronium has rapid onset, and intermediate duration of action. It is commonly marketed under the trade names Zemuron and Esmeron. The drug is associated with the risk of developing allergic reactions in some high-risk patients, such as those with asthma. However, there was a similar incidence of allergic reactions associated with other non-depolarizing neuromuscular blocking
- Synonym type
- Trade Names;synonym
- Synonym
- Esmeron Rocuronium Rocuronium bromide Zemuron
- Xref
- DrugBank: DB00728 PharmGKB: PA164754992 TTD: D0L5CZ
- CAS
- 143558-00-3
- Formular
- C32H53N2O4
- PubChem CID
- CID 441290
- UNII
- WRE554RFEZ
- ATC code
- M03AC09
- Drug Type
- small molecule
- Drug status
- approved
- Source
- PharmGKB;Drugbank
Classification
| PMappKB GV ID | Genomic Location | Alt | ProAlt | Gene symbol | Relation |
|---|
| PMappKB SV ID | Genomic Location | Alt | ProAlt | Gene symbol | Relation |
|---|
| Drug Name | Synonyms | Formular | PubChem_CID | ATC code | Drug Type | Drug Status | Relation |
|---|
| Protein name | Summary | Xref | PMID | Relation |
|---|